Cowen Upgrades ISIS Pharmaceuticals (ISIS) to Outperform
Tweet Send to a FriendGet Alerts ISIS Hot Sheet
Price: $20.81 --0%
Rating Summary:
4 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 20 | New: 11
Rating Summary:
4 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 20 | New: 11
Trade ISIS Now!
Cowen upgraded ISIS Pharmaceuticals (NASDAQ: ISIS) from Neutral to Outperform.
For an analyst ratings summary and ratings history on ISIS Pharmaceuticals click here. For more ratings news on ISIS Pharmaceuticals click here.
Shares of ISIS Pharmaceuticals closed at $7.67 yesterday, with a 52 week range of $6.43-$15.61.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ISIS Pharmaceuticals click here. For more ratings news on ISIS Pharmaceuticals click here.
Shares of ISIS Pharmaceuticals closed at $7.67 yesterday, with a 52 week range of $6.43-$15.61.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- First Analysis Upgrades Volcano Corp. (VOLC) to Overweight
- Stifel Nicolaus Upgrades Dice Holdings (DHX) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
